Objective: To establish the association of cardiotocography (CTG) and other obstetric parameters with pulsed Doppler findings in cerebral arteries during the first day of life, and to compare the cerebral artery Doppler with other determinants of asphyxia in predicting 1-year neurological outcome in asphyxiated full-term infants.
Introduction
The incidence of birth asphyxia has been estimated to be from 3 to 5/1000 live births in the Western world. 1, 2 Half of these infants develop moderate or severe hypoxic-ischemic encephalopathy (HIE) symptoms [1] [2] [3] and 25% will develop neurological impairments. 4, 5 The degree of subsequent neurological problems has been found to be related to the severity of HIE. 5 This varies from grade 1, associated with normal outcome, to grade 3, associated with high mortality and severe neurodevelopmental abnormalities. The HIE grade 2 outcome varies widely from normal development to severe impairment. 3, 6, 7 The prediction of long-term neurodevelopmental outcome has been difficult. The relationship between conventional clinical parameters (Apgar scores, cord blood pH and HIE symptoms) and outcome has been assessed in a number of studies. 6, [8] [9] [10] The presence and severity of HIE by Sarnat criteria has proved a good determinant of neurological outcome, 6, 8 whereas Apgar scores and cord blood pH have been poor predictors of the outcome. [8] [9] [10] Cardiotocography (CTG) is a screening tool used to assess the fetal condition during the labor and to identify the possibility of asphyxia. CTG has a high sensitivity but low specificity for fetal hypoxia or asphyxia. 11 Increased cerebral blood flow velocity (CBFV) and resistive index reduced below 0.55 by pulsed Doppler ultrasonography, have been associated with poor outcome in birth asphyxia assessed at the age from 24 to 72 h. [12] [13] [14] We have previously shown a strong association of increased systolic CBFV in the anterior cerebral (ACA) or in the basilar (BA) arteries at around 24 h of age with adverse neurological outcome at the age of 1 year, whereas reduced resistive index failed to show association with poor outcome (submitted/unpublished data). In this study, we sought to analyse the obstetric parameters, biochemical asphyxia markers, HIE symptoms or their combinations, in predicting the neurological outcome at 1 year in full-term asphyxiated infants.
Patients and methods

Patients
This longitudinal prospective follow-up study was carried out in the neonatal intensive care unit in Tampere University Hospital. The Ethics Committee of Tampere University Hospital had approved the study protocol. Informed consent was obtained from the parents.
In all, 30 full-term (gestational age 37 weeks or more) infants with asphyxia and 30 healthy gestational age-and sex-matched infants, born between July 2000 and September 2003, were enrolled.
Infants were included in the asphyxia group when Apgar scores were 5 or less at the 5th minute of life and if they fulfilled at least one of following criteria for asphyxia: (1) signs of fetal distress such as abnormal CTG or meconium-stained amniotic fluid, (2) cord arterial pH<7.10 or (3) symptoms of HIE within 48 h of life.
For each asphyxiated infant, a non-asphyxiated control infant was enrolled in the postnatal ward. Infants with major congenital malformations likely to affect Apgar scores were excluded. One asphyxiated infant with grade 2 HIE, in whom Kabuki syndrome was diagnosed according to the characteristic features at 2 years and 9 months of age, was included in the analysis.
HIE grading
The severity of HIE was graded (grade from 1 to 3) according to the modified Sarnat criteria. 6 Grading was based on clinical observations (level of consciousness, muscle tone, posture, reflexes, autonomic functions and seizures) during the first 48 h of life. Infants with grade 1 HIE had normal muscle tone and usually recovered well within 12 to 24 h without seizure activity. Infants with altered levels of consciousness and seizure activity from 12 to 24 h after the hypoxic-ischemic event developed grade from 2 to 3 HIE. Further deterioration to grade 3 HIE led to loss of reflex activity, flaccid muscle tone, respiratory failure and coma.
Pulsed Doppler ultrasound examination
The diastolic and systolic CBFV in the ACA and BA arteries was measured through the anterior fontanel, using a 7.5-MHz. transducer (PowerVision 6000, Toshiba, Nasu, Japan) at about 24 h of age (median 29.0; range from 19 to 40 h). The CBFV in the ACA represented the carotid and that in the BA the vertebrobasilar circulation. The CBFV in the ACA was measured in front of the third ventricle and that in the BA in front of the pons cerebri in sagittal section. Peak CBFVs (cm per s) in systole and diastole were measured from 1 to 3 cardiac cycles once a stable velocity recording was obtained. There was no need to use the angle of insonation.
Obstetric parameters
Obstetric data were collected and analyzed by one obstetrician (JU) who was blinded to the Doppler findings in the newborn and the outcomes of the infants. Data from CTG were available in 29 (97%) asphyxia cases and in 28 (93%) controls, either during the whole labor or at admission before the decision to undertake the cesarean section. CTG was classified according to the FIGO criteria (1987) 15 as normal, non-reassuring, pathological or preterminal, taking into account the given time criteria for the occurrence of decreased variability (more than 40 or 60 min for non-reassuring or pathological, respectively). Prolonged bradycardia (<110 beats per min) of more than 10 min duration was included in the criteria for pathological CTG. According to the available CTG changes and other obstetric data, the obstetrician further determined if the fetus had suffered from asphyxia episode lasting longer or less than 1 h. The Apgar scores were evaluated at the age of 1 and 5 min. The cord artery pH and base excess were measured according to the routine practice of the hospital.
Biochemical asphyxia markers
The concentrations of serum creatine kinase, serum neuronspecific enolase and plasma lactate were measured as biochemical asphyxia markers in the asphyxia group on day 1.
The following cut-off values were used for asphyxia: serum neuron-specific enolase used above 40 mg per l, 16 ,17 plasma lactate above 7.5 mmol per l 18 and serum creatine kinase above 1000 U per l. 19 
Neurological outcome
The overall neurological outcome of the infants was assessed clinically at 1 year of age by a pediatric neurologist (KE), who was blinded to the history of the infants. A modified Griffith's scale was used to structure the assessment and only raw scores were noted. Neurological outcome was classified as normal, motor disability or motor and mental disability. Abnormal outcome was defined as any neurological impairment or death.
Statistical analysis
Statistical analyses were performed using SPSS 11.0. and 17.0 for Windows (SPSS, Chicago, IL, USA). Differences between the infants with asphyxia and the healthy control infants, and between the normal and abnormal neurological outcome in the asphyxia group were tested. Mann-Whitney U was used for skew-distributed continuous variables and categorical variables were tested by Pearson's w 2 -square or Fisher's exact test if expected values were too small. A P-value below 0.05 was considered significant.
Sensitivity and specificity of predictive abnormal neurological outcome at 1 year of age or death were calculated for CTG classification, Apgar scores, cord blood pH, biomarkers, HIE grading and Doppler findings, or their combinations in asphyxiated infants. Predictive values with 95% confidence intervals were calculated by confidence interval analysis program version 2.1.2 (University of Southampton, UK).
Results
Clinical characteristics in the study groups and in the asphyxia group with normal and abnormal outcome are seen in Table 1 . In all, 3 asphyxiated infants were lost to the follow-up and 27 (90%) asphyxiated infants were followed up to 1 year of age. Altogether six (22%) had an abnormal outcome. One infant with grade 1 HIE and two with grade 2 HIE evinced delay in motor development at the age of 1 year, one infant with grade 2 HIE had spastic diplegia and 1 with grade 3 HIE had severe cognitive and motor developmental delay at 1 year of age. One infant with grade 3 HIE died at the age of 9 days.
In all, 9 (30%) out of 30 infants with asphyxia recovered well without the HIE symptoms. A total of 21/27 (78%) Normal vs abnormal outcome in the asphyxia group. d Abnormal outcome was defined by pediatric neurologist using a modified Griffth's scale at 1 year of age or death.
e SGA: small for gestational age; < 2500 g in term infant. f One CTG in the asphyxia group and two in the control group were missing. g Three missing data in the asphyxia group. h One pH was not available in the asphyxia group and two in the control group. i Five cord blood base deficits were not available in both the study groups.
follow-up-asphyxiated infants had normal outcome at 1 year of age, 10 (23.8%) with HIE grade 1 and 6 (47.6%) with HIE grade from 2 to 3 and 6 (28.6%) with no HIE symptoms. None of the control infants evinced neurological symptoms at the postnatal ward. A total of 22 (73%) of the 30 controls were followed up to 1 year of age and one of them had delayed motor development at the age of 1 year.
The mean raw scores for Griffith's scale at 1 year of age were 124.4 in those with abnormal neurological outcome and 146.7 for those with normal neurological outcome. However, the Griffith's scale was used merely as a supportive tool for the neurological assessment, and therefore the clinical significance of the difference in these raw scores is minimal.
Pathological CTG recordings were concentrated in the asphyxia group, while less severe, non-reassuring CTG tracings were equally distributed in both the groups. The criteria for totally normal CTG were fulfilled more frequently in the controls than among the asphyxia group. However, the classification of CTG had no association with the neurological outcome within the asphyxia group. Likewise, low Apgar scores, cord blood pH and base excess were more frequent in the asphyxia group, but their distribution did not differ according to the outcome. Neither was the duration of asphyxia episodes related to the outcome (Table 1) .
Plasma lactate was more than 7.5 mmol per l in four (19%) asphyxiated cases with normal outcome and in one case (17%) with abnormal outcome measured at around 24 h, P ¼ 1000; serum NSE more than 40 mg per l in eight cases (38%) with normal outcome and four (37%) with abnormal outcome, respectively, P ¼ 0.357; serum CK>1000 U per l in 11 (55%) asphyxiated cases with normal outcome and in 3 cases (50%) with abnormal outcome, P ¼ 1.000.
Peak systolic CBFV over 50.0 cm per s (mean þ 3 s.d.) in the ACA or over 55 cm per s (mean þ 3 s.d.) in the BA around 24 h of age (from 27 to 37 h of age) was found in 6 (20%) of 30 asphyxiated infants, but none in the control group. Five of these six asphyxiated infants with increased peak systolic CBFV had abnormal outcome at 1 year of age or died in the neonatal period. Peak diastolic CBFV over 20.0 cm per s (mean þ 3 s.d.) in the ACA or in the BA around 24 h of age was measured in five (18%) of the asphyxiated infants, four (67%) of them having abnormal outcome. The CBFVs measured within the first 12 h of life did not differ significantly between the groups. The pathologically increased CBFVs normalized from 3 to 11 days of age, except in the infant with grade 3 HIE who died at 9 days of age. An imagine of high systolic CBFV in the BA by Doppler ultrasound in an aspyhxiated infant with severe HIE is seen in Figure 1 .
Clinical parameters among the asphyxiated cases with increased systolic CBFVs in the ACA or BA at around 24 h of age and adverse neurological outcome are shown in Table 2 .
The distributions of CTG findings in the asphyxiated infants as assessed by the severity of HIE, increased systolic CBFVs around 24 h of age and abnormal outcome at 1 year of age are seen in Table 3 .
For prediction of abnormal outcome at 1 year of age or death in the asphyxia group, increased systolic CBFV (mean þ 3 s.d.) in the ACA or BA at around 24 h of age was the best independent predictor Figure 1 The high systolic CBFV in the BA by Doppler ultrasound in an asphyxiated infant with severe HIE.
( Table 4 ). It found that 5/6 cases with adverse neurological outcome, as did also the presence of HIE grade from 2 to 3, but increased systolic CBFV showed much higher specificity than the HIE grade from 2 to 3. The combination of HIE stage from 2 to 3 and increased systolic CBFV found all cases with adverse outcome. The predictive values of pathological CTG, pH 7.05 or less, the Apgar scores below 4 to 5 min and biochemical asphyxia markers were poor. The absence of pathological increase in systolic CBFVs within the first 24 h of life was the best independent predictor of the normal neurological outcome, even in presence of HIE symptoms (Table 5) .
Discussion
The main finding in this study was that increased systolic CBFVs in the ACA or in the BA around 24 h of life seemed to be associated with poor 1 year outcome in the asphyxia group more clearly than the CTG, acid basement status, Apgar scores or biochemical asphyxia markers, or HIE. The combination of moderate or severe HIE (grade from 2 to 3) and increased systolic CBFV around 24 h of age predicted abnormal outcome even better. On the other hand, if no pathological increase in systolic CBFVs is observed within the first 27 to 37 h of life, the 1-year outcome seems to be Abbreviations: ACA, anterior cerebral artery; BA, basilar artery; CTG, cardiotocography; HIE, hypoxic-ischemic encephalopathy; S-CK, serum creatine kinase; S-NSE, serum neuron-specific enolase. Abbreviations: CTG, cardiotocography; HIE, hypoxic-ischemic encephalopathy. a One CTG was missing. b Abnormal outcome was defined by pediatric neurologist using a modified Griffith's scale at 1 year of age or death.
Cerebral Doppler-predicting outcome of asphyxia MK Julkunen et al good. Only one out of six (17%) asphyxiated infants with increased CBFV had normal outcome at 1 year of age, while 5 out of 10 newborns with HIE grade from 2 to 3 (50%) appeared normal at age of 1 year after the asphyxia event. Assessment of the infants' CBFVs between 27and 37 h of age after birth asphyxia thus seems to provide useful information for discussion with the parents. CBFVs were measured in two cerebral arteries (ACA and BA) by pulsed Doppler ultrasonography. The brain is supplied by four large arteries, two internal carotid arteries and two vertebral arteries. The internal carotid artery divides into two large branches, the ACA and the middle cerebral artery. The two vertebral arteries combine into the unpaired BA artery. The Doppler findings in the ACA and in the BA thus represented both the carotid and vertebrobasilar circulation and yielded reliable information on the cerebral circulation.
Hyperperfusion in the cerebral circulation has been held to be a sign of permanent brain damage in the asphyxiated infants in several Doppler studies. 12, 20, 21 Increased CBFV in the cerebral circulation by the age of 12 h in infants with severe HIE or poor outcome has been reported. 20, 22 Increased CBFV from 24 to 72 h has been taken as a sign of permanent brain damage with poor prognosis in asphyxiated infants, [12] [13] [14] and the present results confirm the findings concerning increased CBFVs.
The criteria for asphyxia are variable in different studies. Even moderate degree of acidemia, pH from 7.10 to 7.15, is associated with an increased risk of low Apgar scores. 23 In a recent General Movements study the cord arterial pH<7.20 was one inclusion criteria for the asphyxia group. 24 The International Cerebral Palsy Task Force (1999) 25 have suggested that intrauterine hypoxia, severe enough to be the cause of HIE and/or cerebral palsy should meet following criteria: Apgar scores from 0 to 6 longer than 5 min, cord arterial pH below 7.00 and base deficit above 12 mmol per l, sentinel event or abrupt fetal heart rate change, moderate or severe neonatal encephalopathy of early onset, affection of other Abbreviations: ACA, anterior cerebral artery; BA, basilar artery; CTG, cardiotocography; CI, confidence interval; HIE, hypoxic-ischemic encephalopathy; S-CK, serum creatine kinase; S-NSE, serum neuron-specific enolase. a In all, 3 of the 30 asphyxiated infants were lost to follow-up. 26 criteria for acute perinatal asphyxia were quite similar, but Apgar scores were lower, 3 or below at 5 min. The ACOG committee criteria for asphyxia are fullfiled quite rarely, only in severely asphyxiated infants. Criteria for birth asphyxia similar to ours have been previously used in the literature. Thus, we chose less strict inclusion criteria, compared with the ACOG criteria.
The Apgar score is a useful basis for assessing the general condition of infants at birth, but it has a limitation in identifying birth asphyxia and predicting neurological outcome. 27 However, infants with low Apgar score from 0 to 3 at 5 min and symptoms of neonatal encephalopathy had an increased risk of subsequent neurodevelopmental impairments and learning difficulties; whereas a similar low Apgar score without neonatal symptoms had no association with a high risk of later impairments compared with the healthy control infants. 28 In another study, the specificity of the combination of the presence of HIE, a base deficit over 20 mmol per l, and an Apgar score below 4 at the age of 5 min for death or adverse outcome was 100% and the sensitivity was 67%. 29 In our study, the specificity of combination of low 5 min Apgar scores and the presence of HIE grade from 2 to 3 to predict adverse outcome was high, but the sensitivity was poor, only 33%.
According to one study, the infants with neonatal encephalopathy had significantly more abnormal (89%) CTG traces (absent accelerations and low variability), but 52% of control CTG traces were also abnormal. 30 In our study, all of the asphyxiated cases with a poor neurological outcome had abnormal CTG, but only half of them had clear pathological recording, while the other half had a CTG of only moderate, 'non-reassuring' classification. At the same time, half of the asphyxiated cases with normal outcome had pathological CTG, and also half of the nonasphyxiated control cases had abnormal CTG. Thus, our findings are consistent with the earlier studies suggesting high false-positive rate of CTG, making it a poor tool in predicting the outcome of asphyxiated children. 7, 11, 29 Several serum, urine or cerebrospinal fluid biomarkers have been examined as markers of outcome in HIE, but none has been studied extensively enough to warrant routine clinical use. 31 In this study, there was likewise no correlation between the blood biomarkers according to the outcome in the asphyxiated.
Conclusion
The values of pathological CTG, Apgar scores, acid basement status and biochemical asphyxia markers in predicting the 1-year outcome of the asphyxiated infants were poor, showing either low sensitivity or low specificity. Severe HIE grade from 2 to 3 was sensitive in predicting adverse neurological outcome, but as the false positive rate was high, the specificity was only 76%. Increased systolic CBFV was superior in predicting adverse outcome, with a high sensitivity and high specificity. Thus, absence of a pathological increase in systolic CBFV after birth asphyxia might be a useful predictor of favorable 1-year neurological outcome.
